Your browser doesn't support javascript.
loading
Patient-Reported Outcomes, Tumor Markers, and Survival Outcomes in Advanced GI Cancer.
Jarnagin, Joy X; Saraf, Anurag; Baiev, Islam; Chi, Gary; van Seventer, Emily E; Mojtahed, Amirkasra; Allen, Jill N; Clark, Jeffrey W; Blaszkowsky, Lawrence; Giantonio, Bruce J; Weekes, Colin D; Klempner, Samuel J; Franses, Joseph W; Roeland, Eric J; Goyal, Lipika; Siravegna, Giulia; Horick, Nora; Corcoran, Ryan B; Nipp, Ryan D; Parikh, Aparna R.
Afiliação
  • Jarnagin JX; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston.
  • Saraf A; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston.
  • Baiev I; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston.
  • Chi G; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston.
  • van Seventer EE; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston.
  • Mojtahed A; Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston.
  • Allen JN; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston.
  • Clark JW; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston.
  • Blaszkowsky L; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston.
  • Giantonio BJ; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston.
  • Weekes CD; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston.
  • Klempner SJ; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston.
  • Franses JW; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston.
  • Roeland EJ; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston.
  • Goyal L; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston.
  • Siravegna G; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston.
  • Horick N; Department of Statistics, Massachusetts General Hospital and Harvard Medical School, Boston.
  • Corcoran RB; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston.
  • Nipp RD; OU Health Stephenson Cancer Center, Section of Hematology and Oncology, Department of Internal Medicine, The University of Oklahoma (OU) College of Medicine, Oklahoma City.
  • Parikh AR; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston.
JAMA Netw Open ; 6(11): e2343512, 2023 Nov 01.
Article em En | MEDLINE | ID: mdl-37976066

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Qualidade de Vida / Neoplasias Gastrointestinais Limite: Female / Humans / Male Idioma: En Revista: JAMA Netw Open Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Qualidade de Vida / Neoplasias Gastrointestinais Limite: Female / Humans / Male Idioma: En Revista: JAMA Netw Open Ano de publicação: 2023 Tipo de documento: Article